U.S. Booster Plan Scaled Back; U.K Eases Travel: Virus Update
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
The Covid-19 vaccine booster shot proposed by Pfizer Inc. and BioNTech SE should be given to a smaller group of people who are the most vulnerable to serious disease, a panel of expert advisers to the U.S. Food and Drug Administration said. The move is a setback to a sweeping plan from the Biden administration to roll out booster shots to a broad population next week.